[1]
A. Tokito, N. Koriyama, and Y. Nishio, “Long-Term Observation of Improvement in Liver Fibrosis Index by A Glucagon-Like Peptide-1 Receptor Agonist in A Patient with Type 2 Diabetes: A Case Report”, acmcr, vol. 4, no. 2, pp. 292–301, Apr. 2020.